Product Information
ZIPRASIDONE HCL 60 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3293 per EA under NDC 33342014609. Its NADAC has been published 471 times since Aug 16, 2017.
FDA first approved this application on Feb 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342014609
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ZIPRASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204375FDA Approved
2/17/2017
TE Code
AB
On Market Since
2/18/2017
Pharmacological Classes
Price Statistics
The NADAC for ZIPRASIDONE HCL 60 MG CAPSULE has been published 471 times since Aug 16, 2017, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3293 per EA |
|---|---|
| All-time high | $0.6864 (May 16, 2018) |
| All-time low | $0.2545 (Nov 20, 2024) |
| 52-week high | $0.3372 |
| 52-week low | $0.3159 |
| Median price | $0.3698 |
| Average price | $0.3984 |
| Largest weekly change | +29.3% (Aug 21, 2024) |
| Weeks tracked | 471 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZIPRASIDONE HCL 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE HCL 60 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.3293 per EA (NDC 33342014609), effective Aug 19, 2026.
How has the price of ZIPRASIDONE HCL 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZIPRASIDONE HCL 60 MG CAPSULE has declined 49.3%. It has been tracked across 471 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for ZIPRASIDONE HCL 60 MG CAPSULE?
Since Aug 16, 2017, the NADAC for ZIPRASIDONE HCL 60 MG CAPSULE has ranged from a low of $0.2545 (Nov 20, 2024) to a high of $0.6864 (May 16, 2018), with a median of $0.3698 per EA.
Are there cheaper alternatives to ZIPRASIDONE HCL 60 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZIPRASIDONE HCL 60 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ZIPRASIDONE HCL 60 MG CAPSULE?
ZIPRASIDONE HCL 60 MG CAPSULE (NDC 33342014609) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.